Responsive image

Save this Event to your Calendar


The Scientific Program will be realized based on the Central European Summer Time (CEST) + 1 hr

Scientific Program

Monday 08-11-2021

       

16.25-16.30 Welcome and introductions G. Dimopoulos(Greece)

16.30-17.00

Satellite Lecture
Chair: TBA

Speaker
16.30-16.50 TBA TBA
16.50-17.00 Q & A / Discussion  

       

17.00-17.45

Management of the critically ill patients in the Emergency Department (ED) and ICU: different pieces of the same puzzle
Chair: Filippatos G


Speaker
17.00-17.15 ...ICU point of view P. Myrianthefs
17.15-17.30 ...ED point of view E. Polyzogopoulou
17.30-17.45 Q & A / Discussion  

       

17.45-18.15

Satellite Lecture
Chair: TBA

Speaker
17.45-18.05 TBA TBA
18.05-18.15 Q & A / Discussion  

       

18.15-19.00

Satellite Symposium
Chair: TBA

Speaker
18.15-18.35 TBA TBA
18.35-18.55 TBA TBA
18.55-19.00 Q & A / Discussion  

         

19.00-20.45

New concepts in the management of the critically ill patient in the ED
Chair: Parissis J

Speaker
19.00-19.15 Point of care ultrasound in undifferentiated shock E. Polyzogopoulou
19.15-19.30 Role of biomarkers K. Ntai
19.30-19.45 Advances in the airway management A. Boultadakis
19.45-20.00 ECMO in the ED S. Dimopoulos
20.00-20.15 Advances in management of cardiogenic shock J. Parissis
20.15-20.45 Q & A / Discussion

Tuesday 09-11-2021

       

09.00-11.00

Fungal Infections
Chairs: Zaoutis T- Magira H

Speaker
09.00-09.15 IFIs : The epideliology is changing I. Martin-Loeches
09.15-09.30 Antifungal stewardship J.A. Paiva
09.30-09.45 A breakthrough IFI: how to treat it ? M. Ghannoum
09.45-10.00 The optimal antifungal dose? P. Montravers
10.00-10.15 Rare mould infections: The new guidelines O. Cornely
10.15-10.30 Pathogenesis of fungal-bacterial mixed biofilms M. Richardson
10.30-11.00 Q & A / Discussion  

       

11.00-12.00

Satellite Symposium
Chair: TBA

Speaker
11.00-11.45 TBA TBA
11.45-12.00 Q & A / Discussion  

     

12.00-13.00 Break

     

13.00-14.45

How to treat...
Chairs: Pana Z.D. - Dimopoulou I.M

Speaker
13.00-13.15 …XDR/PDR infections M. Akova
13.15-13.30 …MDR endocarditis E. Giannitsioti
13.30-13.45 …CAP patients I. Martin-Loeches
13.45-14.00 …and for how long Legionella spp pneumonia J.A. Paiva
14.00-14.15 …cSSTIs C. Eckmann
14.15-14.45 Q & A / Discussion  

     

14.45-15.00 Break

         

15.00-16.45

Sepsis and other
Chairs: Kotanidou A - Rovina N

Speaker
15.00-15.15 Genetic predisposition against fungi? M. Richardson
15.15-15.30 Artificial Intelligence and infections I. Mporas
15.30-15.45 Biomarkers in sepsis: any specific for different patient groups? E. Eckmann
15.45-16.00 PCT guided antimicrobials M. Akova
16.00-16.15 Antibiotic resistance in bacterial biofilms: How is trasmitted M. Ghannoum
16.15-16.45 Q & A / Discussion

     

16.45-17.00 Break

         

17.00-18.00

Satellite Symposium
Chairs: TBA

Speaker
17.00-17.20 TBA TBA
17.20-17.40 TBA TBA
17.40-18.00 Q & A / Discussion  

         

18.00-19.00

T2MR
Chairs: TBA

Speaker
18.00-18.20 T2Biosystems: Enabling Changes in Clinical Decisions and Outcomes M. Broek-Kuehbauch
18.20-18.40 Evaluation of T2MR in a Greek university intensive care unit C. Vrettou
18.40-19.00 Q & A / Discussion  

Wednesday 10-11-2021

       

09.00-11.00

COVID-19 Pandemic I
Chairs: Koulouris N - Komnos A

Speaker
09.00-09.15 The 5 phenotypes of COVID-19 J. Rello
09.15-09.30 Pathophysiology of COVID-19 J.F. Timsit
09.30-09.45 Hypercoagulable phase of COVID-19 S. Konstandinides
09.45-10.00 COVID-19 and PRES syndrome S. Mentzelopoulos
10.00-10.15 The mechanism of immune response to COVID-19 E. Giamarellos
10.15-10.30 How to ventilate COVID-19 patients D. Georgopoulos
10.30-11.00 Q & A / Discussion  

       

11.00-12.00

Satellite Symposium
Chair: TBA

Speaker
11.00-11.45 TBA TBA
11.45-12.00 Q & A / Discussion  

     

12.00-13.00 Break

     

13.00-14.45

COVID-19 Pandemic II
Chairs: Sambatakou H - Stratakos G

Speaker
13.00-13.15 COVID Associated Aspergillosis O. Cornely
13.15-13.30 Other IFIs associated with COVID-19 P. Montravers
13.30-13.45 Secondary Bacterial Infections in COVID patients M. Kollef
13.45-14.00 Pulmonary complications of COVID-19 J.F Timsit
14.00-14.15 Cardiac complications of COVID-19 I. Ikonomidis
14.15-14.45 Q & A / Discussion  

     

14.45-15.00 Break

         

15.00-16.45

COVID-19 Pandemic III
Chairs: Pana Z.D. - Bakakos P

Speaker
15.00-15.15 Anticoagulant therapy in COVID-19 patients S. Konstandinides
15.15-15.30 COVID in immunocompromised patients E. Azoulay
15.30-15.45 Antiviral treatment M. Bassetti
15.45-16.00 Antiiflammatory treatment E. Giamarellos
16.00-16.15 Plasma treatment M.A. Dimopoulos
16.15-16.45 Q & A / Discussion

     

16.45-17.00 Break

         

17.00-18.00

Satellite Symposium
Chairs: TBA

Speaker
17.00-17.20 TBA TBA
17.20-17.40 TBA TBA
17.40-18.00 Q & A / Discussion  

         

18.00-19.00

Infections Prevention
Chairs: Zaoutis T - Faropoulos J

Speaker
18.00-18.20 TBA TBA
18.20-18.40 TBA TBA
18.40-19.00 Q & A / Discussion  

Thursday 11-11-2021

       

09.00-11.00

Infections in transplant patients
Chairs: Koutsoukou A - Arkadopoulos N

Speaker
09.00-09.15 Fungal infections in transplant patients J. Meletiadis
09.15-09.30 Bacterial infections in transplant patients J. Rello
09.30-09.45 Viral infections in transplant patients J. Chastre
09.45-10.00 Infections in haematopoetic stem cell transplantation E. Terpos
10.00-10.15 Antifungal prophylaxis in lung transplant patients M. Bassetti
10.15-10.30 Sepsis in solid organ transplant: a different outcome? E. Azoulay
10.30-11.00 Q & A / Discussion  

       

11.00-12.00

Satellite Symposium
Chair: TBA

Speaker
11.00-11.45 TBA TBA
11.45-12.00 Q & A / Discussion  

     

12.00-13.00 Break

     

13.00-14.45

PK/PDs in the critically ill patient
Chairs: Faropoulos J - Dokoumetzidis A

Speaker
13.00-13.15 TDM: antibiotic, patient, infection. When and how? R. Lewis
13.15-13.30 PK/PDs from the part of the pharmacist C. Petrou
13.30-13.45 PK/PDs of antibiotics in pregnancy D. Nicolau
13.45-14.00 An ICU patient on CRRT or ECMO: which is the right dose? R. Lewis
14.00-14.15 %TMIC is enough for the confirmation of the adequate dose? D. Nicolau
14.15-14.45 Q & A / Discussion  

     

14.45-15.00 Break

         

15.00-16.45

The future
Chairs: Orfanos S - Myrianthefs P

Speaker
15.00-15.15 Molecular imaging of pathogens S. Pournaras
15.15-15.30 Bacteriophages; the futured treatemnt of infections? M. Kollef
15.30-15.45 Metabolomics in sepsis M. Netea
15.45-16.00 Monoclonal antibodies for preemptive treatment of bacterial infections in the ICUt J. Chastre
16.00-16.15 Sepsis endotypes M. Netea
16.15-16.45 Q & A / Discussion

     

16.45            End of Meeting